The Food and Drug Administration awarded a purchase order to Xenturis LLC for a high-density 2D multi-electrode array electrophysiology platform valued at $357,231.40 on September 29, 2026. Xenturis is a service-disabled veteran-owned small business based in Missoula, Montana. Place of performance is Missoula, MT. The order covers hardware, software, accessories, initial consumables, installation, system verification, calibration, training, and two-year manufacturer warranty. The platform must deliver at least 2,000 electrodes per recording well at 10 kHz sampling rate, 1,000 simultaneous electrodes at 20 kHz, spatial resolution of 30 micrometers or less, and multi-well capability with Windows-based software. Installation and all commissioning activities must complete within 75 calendar days of delivery. The solicitation was posted September 14, 2026, with quotations due September 23, 2026, and was awarded on a lowest-price-technically-acceptable basis.